Skip to content
Cannabis stocks headed lower Tuesday after a Monday communication from the FDA, which sent warning letters to 13 companies for illegally selling products containing containing cannabidiol (CBD), violating the Federal Food, Drug, and Cosmetic Act. The 15 companies were warned for marketing CBD products for therapeutic uses in humans and/or animals as well as as dietary supplements. The FDA continues to maintain a strict stance on regulating the consumer CBD market, Bank of America Merrill Lynch analyst Christopher Carey said in his review of the dual communications from the FDA....
In a new interview, former Papa John’s CEO John Schnatter accused Papa John's of changing the recipe to its famous pizza. The ousted CEO....
A federal judge on Tuesday partially overturned the conviction of Insys Therapeutics Inc's founder and three former executives accused of bribing doctors to prescribe an addictive opioid, but declined to disturb the remainder of the jury's verdict. U.S. District Judge Allison Burroughs in Boston ruled the evidence prosecutors presented at trial did not support finding that John Kapoor and the others intended for doctors to prescribe the drug, Subsys, to patients who did not need it. Burroughs said she only "very reluctantly" was overturning part of the jury's May guilty verdict in the case, and said her ruling should not be taken as condoning the "reprehensible" behavior of Kapoor and his co-defendants....
Khiron Life Sciences Corp (OTC: KHRNF) (CSE: KHRN) reported third-quarter revenue of CA$2.8 million ($2.1 million) on Tuesday and a CA$47.9 million cash balance. The company announced a net loss for the quarter of CA$10.6 million, or CA$0.09 per share, versus a net loss of CA$5.2 million in the third quarter of 2018....
(Bloomberg) -- Dell Technologies Inc. reported quarterly profit that topped Wall Street estimates, in a sign that corporate demand for computers and storage hardware remains strong.Earnings, excluding some items, were $1.75 a share in the fiscal third quarter, the Round Rock, Texas-based company said Tuesday in a statement. Analysts, on average, projected $1.59, according to data compiled by Bloomberg. Adjusted revenue rose 1.2% to $22.9 billion in the period ended Nov. 1, just missing analysts’ estimates of $23 billion.Chief Executive Officer Michael Dell has sought to outperform peers by diversifying his company’s product portfolio. Macroeconomic forces, including trade and geopolitical tensions, have caused Dell’s clients to slow down their data-center hardware purchases. Hewlett Packard Enterprise Co. and Cisco Systems Inc. said earlier this month that businesses have been more cautious due to global uncertainty.Dell’s revenue growth is helped by its majority interest in software maker VMware Inc., while the company’s personal...
Before your long-term care insurance or disability insurance coverage kicks in, you may be disabled or hospitalized for a length of time. This period is known as the elimination period. Read on discover how an elimination period can impact your … Continue reading ->The post What is an Elimination Period? appeared first on SmartAsset Blog....
(Bloomberg) -- HP Inc. gave a profit forecast that topped Wall Street estimates, projecting optimism that a broad restructuring will pay off while spurning a takeover offer from Xerox Holdings Corp.Profit, excluding some items, will be $2.24 a share to $2.32 a share in fiscal 2020, the Palo Alto, California-based company said Tuesday in a statement. Analysts, on average, estimated $2.24, according to data compiled by Bloomberg. In the fiscal fourth quarter, the hardware maker’s sales and adjusted profit topped analysts’ projections.HP’s earnings report comes in the midst of an increasingly contentious debate with Xerox about a blockbuster combination that would reshape the printing industry. Xerox said Tuesday it plans to go directly to HP’s shareholders, adding that HP’s refusal to engage on the $22-a-share offer “defies logic.”On Sunday, HP reiterated its stance that it has many options to create value for shareholders, other than accepting the offer valued at more...
